Reproducibility of the Capsaicin-induced Dermal Blood Flow Response As Assessed by Laser Doppler Perfusion Imaging

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2007 Jun 21

PMID 17578484

Citations 18

Authors

B J Van der Schueren

J N de Hoon

F H Vanmolkot

A Van Hecken

M Depre

S A Kane

I De Lepeleire

S R Sinclair

Affiliations

Soon will be listed here.

Abstract

Aims: Part I: to establish the dose and appropriate application site of capsaicin on the human forearm in order to produce a robust and reproducible dermal blood flow (DBF) response. Part II: to evaluate the within-subject arm-to-arm and period-to-period reproducibility.

Methods: Both parts consisted of two study visits. In part I, placebo and 100, 300 and 1000 microg capsaicin were applied at four predefined sites on the volar surface of both forearms. Placebo and capsaicin doses were randomized and balanced by site between subjects. Changes in DBF were assessed by laser Doppler perfusion imaging up to 60 min after capsaicin application. In part II, only 1000 microg capsaicin was applied on the proximal forearm and changes in DBF assessed up to 30 min (t(30)). DBF response was expressed as percent change from baseline +/- SD and the corresponding AUC(0-30). Reproducibility assessment included calculation of the concordance correlation coefficient (CCC).

Results: Part I (n = 12 subjects): compared with placebo, 300 and 1000 microg capsaicin increased DBF (P < 0.05) at all time points except at 10 min. This increase was reproducible at the two most proximal sites from the 30-min time point onwards when compared between arms (CCC >or= 0.8, i.e. substantial to almost perfect reproducibility). In part II (n = 11), t(30) averaged 390 +/- 120% and arm-to-arm reproducibility was almost perfect (CCC = 0.91) for AUC(0-30).

Conclusions: Capsaicin induces a reproducible within-subject arm-to-arm increase in DBF. We provide a non-invasive pharmacodynamic model in humans to test antagonists of mediators involved in capsaicin-induced dermal vasodilation, including calcitonin gene-related peptide antagonists.

Citing Articles

Atogepant: Mechanism of action, clinical and translational science.

Boinpally R, Shebley M, Trugman J Clin Transl Sci. 2024; 17(1):e13707.

PMID: 38266063 PMC: 10777605. DOI: 10.1111/cts.13707.

Ubrogepant: Mechanism of action, clinical and translational science.

Boinpally R, Shebley M, Trugman J Clin Transl Sci. 2024; 17(1):e13675.

PMID: 38266060 PMC: 10777434. DOI: 10.1111/cts.13675.

Serotonergic Modulation of Neurovascular Transmission: A Focus on Prejunctional 5-HT Receptors/Mechanisms.

Gonzalez-Hernandez A, Marichal-Cancino B, MaassenVanDenBrink A, Villalon C Biomedicines. 2023; 11(7).

PMID: 37509503 PMC: 10377335. DOI: 10.3390/biomedicines11071864.

Revisiting dose-finding of monoclonal antibodies in migraine.

Al-Hassany L, Karsan N, Lampl C, Goadsby P, MaassenVanDenBrink A J Headache Pain. 2023; 24(1):69.

PMID: 37296378 PMC: 10251584. DOI: 10.1186/s10194-023-01602-4.

Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation.

Chang C, Cai Z, Hsu S Front Pharmacol. 2022; 13:1040951.

PMID: 36569288 PMC: 9772450. DOI: 10.3389/fphar.2022.1040951.

References

Morris S, Shore A . Skin blood flow responses to the iontophoresis of acetylcholine and sodium nitroprusside in man: possible mechanisms. J Physiol. 1996; 496 ( Pt 2):531-42. PMC: 1160896. DOI: 10.1113/jphysiol.1996.sp021704. View

Del Bianco E, Geppetti P, Zippi P, Isolani D, Magini B, Cappugi P . The effects of repeated dermal application of capsaicin to the human skin on pain and vasodilatation induced by intradermal injection of acid and hypertonic solutions. Br J Clin Pharmacol. 1996; 41(1):1-6. DOI: 10.1111/j.1365-2125.1996.tb00151.x. View

Caterina M, Schumacher M, Tominaga M, Rosen T, Levine J, Julius D . The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997; 389(6653):816-24. DOI: 10.1038/39807. View

Veves A, Saouaf R, Donaghue V, Mullooly C, Kistler J, Giurini J . Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes. 1997; 46(11):1846-52. DOI: 10.2337/diab.46.11.1846. View

Wallengren J . Vasoactive peptides in the skin. J Investig Dermatol Symp Proc. 1997; 2(1):49-55. DOI: 10.1038/jidsymp.1997.11. View

Tominaga M, Caterina M, Malmberg A, Rosen T, Gilbert H, Skinner K . The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron. 1998; 21(3):531-43. DOI: 10.1016/s0896-6273(00)80564-4. View

Nagy I, Rang H . Noxious heat activates all capsaicin-sensitive and also a sub-population of capsaicin-insensitive dorsal root ganglion neurons. Neuroscience. 1999; 88(4):995-7. DOI: 10.1016/s0306-4522(98)00535-1. View

Szallasi A, Blumberg P . Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev. 1999; 51(2):159-212. View

Sanchez M, Binkowitz B . Guidelines for measurement validation in clinical trial design. J Biopharm Stat. 1999; 9(3):417-38. DOI: 10.1081/BIP-100101185. View

10.

Porszasz J, JANCSO N . Studies on the action potentials of sensory nerves in animals desensitized with capsaicine. Acta Physiol Acad Sci Hung. 1959; 16:299-306. View

11.

Hershey J, Corcoran H, Baskin E, Salvatore C, Mosser S, Williams T . Investigation of the species selectivity of a nonpeptide CGRP receptor antagonist using a novel pharmacodynamic assay. Regul Pept. 2005; 127(1-3):71-7. DOI: 10.1016/j.regpep.2004.10.010. View

12.

Vanmolkot F, de Hoon J . Reproducibility of forearm vasodilator response to intra-arterial infusion of calcitonin gene-related peptide assessed by venous occlusion plethysmography. Br J Clin Pharmacol. 2005; 59(4):387-97. PMC: 1884797. DOI: 10.1111/j.1365-2125.2005.02333.x. View

13.

Gazerani P, Andersen O, Arendt-Nielsen L . A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain. 2005; 118(1-2):155-63. DOI: 10.1016/j.pain.2005.08.009. View

14.

Quiroz J . Assessment of equivalence using a concordance correlation coefficient in a repeated measurements design. J Biopharm Stat. 2005; 15(6):913-28. DOI: 10.1080/10543400500265652. View

15.

Kubli S, Waeber B, Feihl F . Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function. J Cardiovasc Pharmacol. 2000; 36(5):640-8. DOI: 10.1097/00005344-200011000-00014. View

16.

Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov P . Acute effects of substance P and calcitonin gene-related peptide in human skin--a microdialysis study. J Invest Dermatol. 2000; 115(6):1015-20. DOI: 10.1046/j.1523-1747.2000.00142.x. View

17.

Caterina M, Julius D . The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci. 2001; 24:487-517. DOI: 10.1146/annurev.neuro.24.1.487. View

18.

Goadsby P, Lipton R, Ferrari M . Migraine--current understanding and treatment. N Engl J Med. 2002; 346(4):257-70. DOI: 10.1056/NEJMra010917. View

19.

Fullerton A, Stucker M, Wilhelm K, Wardell K, Anderson C, Fischer T . Guidelines for visualization of cutaneous blood flow by laser Doppler perfusion imaging. A report from the Standardization Group of the European Society of Contact Dermatitis based upon the HIRELADO European community project. Contact Dermatitis. 2002; 46(3):129-40. DOI: 10.1034/j.1600-0536.2002.460301.x. View

20.

Fullerton A, Rode B, Serup J . Studies of cutaneous blood flow of normal forearm skin and irritated forearm skin based on high-resolution laser Doppler perfusion imaging (HR-LDPI). Skin Res Technol. 2002; 8(1):32-40. DOI: 10.1046/j.0909-752x.2001.10327.x. View